It is becoming increasingly more difficult for America’s Office Of National Drug Control Policy (ONDCP) to continue to claim that cannabis is not a valuable and acceptable medicine. Late Wednesday night Austria’s parliament placed the country in line with a number of other countries (i.e., Canada) and 12 American states that allow seriously-ill, dying or sense-threatened medical patients who possess a physician’s recommendation to legally possess and use cannabis medicinally.

VIENNA (AFP) – Austria’s parliament has adopted a new bill allowing the cultivation of cannabis for medical and scientific purposes, under the Health Ministry’s control.The bill, approved by parliament during a late-night session Wednesday, will give the health and food safety agency AGES the exclusive right in Austria to grow the plant, which is otherwise categorised as a drug.

Michael Bach, president of the Austrian pain studies association OeSG, welcomed the new legislation, saying: “Any initiative that makes it possible to develop and provide new drugs for pain therapy is welcome.”

“Substances drawn from cannabis have been used for medical purposes more and more in the last few years,” he added.
Possession of or dealing in cannabis incurs a 6-month prison sentence in Austria.

A funny thing happens when the US government begrudgingly allows for double-blind, placebo-controlled clinical trials evaluating the therapeutic efficacy of inhaled cannabis.  

Investigators discover time after time that it works! 

Here are the results from the latest study, conducted at California’s Center for Medical Cannabis Research.   

Low-dose pot eases pain while keeping mind clear
via Reuters News Wire

NEW YORK (Reuters Health) — Giving carefully calibrated doses of smoked marijuana to people with neuropathic pain, which can be difficult-to-treat and extremely painful, can ease their pain without clouding their minds, California researchers report.

Read the full story here. 

Unfortunately, according to recently released legal filings, fewer than 20 investigators in the United States currently possess federal approval to conduct legal clinical research on whole smoked cannabis. (Not surprisingly, most of these researchers are conducting trials that seek to assess the potential physical and mental harms allegedly associated with the drug.) In addition, state funding for the CMCR — which has backed virtually all of the medical cannabis research conducted over the past several years — has dried up and no new appropriations are likely.

Of course, federal officials could readily step in with grant money to keep this important clinical research going — after all, just last month the US National Institute on Drug Abuse announced that it would be spending millions to establish the first-ever ‘Center on Cannabis Addiction‘ — but, needless to say, I’m not holding my breath.

Michigan voters will be deciding on more than just the next President this November; they will also be voting on whether to make Michigan the thirteenth state to authorize the use of medical cannabis.

Full Story